ASX release: Management and Board Changes

ASX Release

AAMG announces management and board changes

Singapore, 20 January 2020 - Asian American Medical Group Limited (ASX:AJJ) ("AAMG" or the "Company") announces several management and Board changes, including the resignations of Group Chief Operating Officer ("GCOO") Mr Cherinjit Kumar Shori and Group Chief Financial Officer ("GCFO") Mr Meng Yau Yeoh.

Mr Shori's last day in the Company will be on 31 January 2020 while Mr Yeoh will assume the post of Advisor from 28 February 2020.

As part of the Group's strategic internal reorganisation to achieve better efficiency and cost effectiveness announced at its Annual General Meeting on 6 December 2019, AAMG will disband its Commercial Division and its duties absorbed into the Finance Division. Chief Commercial Officer Ms Angela Choong will be promoted and re-designated to GCFO, taking over from Mr Yeoh.

Prior to joining AAMG in August 2015, Ms Choong was the finance director and regional financial controller of a European MNC in the manufacturing industry. She has over 25 years of regional business partnering experience with a strong track record in finance, risk management, management of new factory construction projects and implementation of business improvement projects across China, Taiwan, Hong Kong and Southeast Asia. She is a fellow member of Chartered Institute of Management Accountants United Kingdom and member of the Institute of Singapore Chartered Accountants.

Meanwhile, Executive Chairman Dato' Dr Kai Chah Tan will assume the role of GCOO until a replacement is found.

1

Mr Heng Boo Fong will also relinquish his position as Lead Independent Non-Executive Director

with effect from 1 February 2020, due to his other work commitments. As he held the position

for more than 10 years, Mr Fong felt that the change will be good for corporate governance

reasons. Consequently, he will also step down as Chairman of the Audit and Nomination and

Remuneration Committees, which will be taken over by fellow Board member Mr Pang Fey Yu.

Mr Peter Hurley will be appointed as a member of the Audit Committee.

Commenting on the changes to the Company, Dr Tan said: "I would like to thank Jit and Meng

Yau for their dedicated service to the Company. They have worked hard to help us achieve

significant corporate milestones throughout the decade that they have served. I wish both of

them the very the best in their future endeavours as they pursue other interests and I am

grateful that Meng Yau will continue to be engaged as an Advisor to the Company."

"I am also grateful to Heng Boo for his contributions to the Board in the last 10 years. His wise

counsel will be missed at our board meetings."

- The End -

About Asian American Medical Group

Singapore-based and Australian Securities Exchange-listed Asian American Medical Group ("AAMG") operates leading liver and radiation centres in Singapore. Established in 1994, its Asian American Liver Centre is one of Asia's foremost liver centres led by renowned hepatobiliary expert and liver transplant surgeon, Dato' Dr Tan Kai Chah who helped start the Liver Transplant Programme at the King's College Hospital London, and pioneered the Living Donor Liver Transplantation Programme in Singapore.

AAMG's Asian American Radiation & Oncology Pte Ltd ("AARO") was established in March 2015 and is led by Dr Daniel Tan Yat Harn. It offers radiation and oncology clinical services, consultancy and management services. AARO will drive expansion of the Group's growing radiotherapy and oncology segment in overseas markets.

2

AAMG also provides healthcare management and consultancy services for healthcare overseas projects. It also manages healthcare real estate, including the development of AAMG's cancer centre in Johor, Malaysia.

For further information, please visit www.aamg.co.

Media enquiries
Catherine Ong Associates Pte Ltd
Catherine Ong	Ashley Silitonga
Mobile: [phone]	Mobile: [phone]
Email:[e-mail]	Email:[e-mail]

3